Molecular model of the Covid-19 drug Nirmatrelvir (red) binding to and inhibiting the the 3C-like protease (blue) of the SARS-CoV-2 virus. Nirmatrelvir is an antiviral medication developed to treat Covid-19, which is caused by the SARS-CoV-2 virus. 3C-like protease, also known as main protease, processes two long polyproteins that the virus needs to replicate new viruses.

px px dpi = cm x cm = MB
Details

Creative#:

TPG33249849

Source:

達志影像

Authorization Type:

RF

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

N/A

Right to Privacy:

No

Same folder images:

Same folder images